Article Details
Retrieved on: 2021-07-23 13:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The FDA has now approved AstraZeneca's convenient once-a-week glucose lowering drug for 10 to 17-year-olds with type 2 diabetes. In a pivotal trial ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here